Engineered ferritin for lanthanide binding

PLoS One. 2018 Aug 13;13(8):e0201859. doi: 10.1371/journal.pone.0201859. eCollection 2018.

Abstract

Ferritin H-homopolymers have been extensively used as nanocarriers for diverse applications in the targeted delivery of drugs and imaging agents, due to their unique ability to bind the transferrin receptor (CD71), highly overexpressed in most tumor cells. In order to incorporate novel fluorescence imaging properties, we have fused a lanthanide binding tag (LBT) to the C-terminal end of mouse H-chain ferritin, HFt. The HFt-LBT possesses one high affinity Terbium binding site per each of the 24 subunits provided by six coordinating aminoacid side chains and a tryptophan residue in its close proximity and is thus endowed with strong FRET sensitization properties. Accordingly, the characteristic Terbium emission band at 544 nm for the HFt-LBT Tb(III) complex was detectable upon excitation of the tag enclosed at two order of magnitude higher intensity with respect to the wtHFt protein. X-ray data at 2.9 Å and cryo-EM at 7 Å resolution demonstrated that HFt-LBT is correctly assembled as a 24-mer both in crystal and in solution. On the basis of the intrinsic Tb(III) binding properties of the wt protein, 32 additional Tb(III) binding sites, located within the natural iron binding sites of the protein, were identified besides the 24 Tb(III) ions coordinated to the LBTs. HFt-LBT Tb(III) was demonstrated to be actively uptaken by selected tumor cell lines by confocal microscopy and FACS analysis of their FITC derivatives, although direct fluorescence from Terbium emission could not be singled out with conventional, 295-375 nm, fluorescence excitation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoferritins / chemistry*
  • Apoferritins / genetics
  • Apoferritins / metabolism*
  • Binding Sites
  • Cell Line, Tumor
  • Escherichia coli
  • Humans
  • Lanthanoid Series Elements / chemistry*
  • Mice
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Protein Binding
  • Protein Engineering

Substances

  • Lanthanoid Series Elements
  • Apoferritins

Grants and funding

This study has received funding from the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement nº 312284. The biological part of the study was supported by the grant from National Science Centre (NCN) in Poland no. UMO-2015/18/E/NZ6/00642.EU H2020 Project “X-Probe”, Grant N° 637295, to A. Bonamore and M.C.T. is gratefully acknowledged. Flagship project “Nanomax” from MIUR to A. Boffi is also acknowledged. The funder provided support in the form of salaries for authors Trabuco, MC, who is employed at Molirom as a Marie Curie Fellow within the framework of the X-probe EU project, and Taciak B., Rygel T and Krol M., who are employed at Cellis within the framework of the National Science Center of Poland. The companies did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.